Adaptive Biotechnologies (ADPT) Return on Capital Employed (2019 - 2026)
Adaptive Biotechnologies (ADPT) posted Return on Capital Employed of 11.06% for Q1 2026, up 20.25% sequentially from 13.87% in Q4 2025, and up 2173.0% YoY from 0.49% in Q1 2025.
Adaptive Biotechnologies (ADPT) Return on Capital Employed (2019 - 2026) Analysis & Trends
Adaptive Biotechnologies (ADPT) has 8 years of Return on Capital Employed data on file, last reported at 11.06% in Q1 2026.
- Quarterly Return on Capital Employed rose 2173.0% year-over-year to 11.06% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 11.06% (up 2173.0% YoY) and the FY2025 annual result came in at 13.1%, up 1927.0% from the prior year.
- Return on Capital Employed rose to 11.06% in Q1 2026 per ADPT's latest filing, from 13.87% in the prior quarter.
- The five-year high for Return on Capital Employed was 11.06% in Q1 2026, with the low at 42.39% in Q2 2024.
- Average Return on Capital Employed over 5 years is 29.75%, with a median of 30.02% recorded in 2022.
- Year-over-year, Return on Capital Employed sank 1462 bps in 2024 and surged 2221 bps in 2025.
- Adaptive Biotechnologies' Return on Capital Employed stood at 26.32% in 2022, then slumped by 43 bps to 37.75% in 2023, then rose by 5 bps to 36.05% in 2024, then jumped by 62 bps to 13.87% in 2025, then grew by 20 bps to 11.06% in 2026.
- Business Quant data shows ADPT's Return on Capital Employed at 11.06% in Q1 2026, 13.87% in Q4 2025, and 19.06% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 4.82% |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 8.12% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 6.26% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 67.98% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -3.63% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 14.57% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 10.24% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 16.90% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 45.73% |
| 10 | Adaptive Biotechnologies | 3.48 Bn | 3.27 Bn | 52.17 Mn | -11.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.06% |
| Dec 31, 2025 | -13.87% |
| Sep 30, 2025 | -19.06% |
| Jun 30, 2025 | -29.42% |
| Mar 31, 2025 | -32.79% |
| Dec 31, 2024 | -36.05% |
| Sep 30, 2024 | -41.27% |
| Jun 30, 2024 | -42.39% |
| Mar 31, 2024 | -39.19% |
| Dec 31, 2023 | -37.75% |
| Sep 30, 2023 | -30.12% |
| Jun 30, 2023 | -27.78% |
| Mar 31, 2023 | -26.48% |
| Dec 31, 2022 | -26.32% |
| Sep 30, 2022 | -30.02% |
| Jun 30, 2022 | -32.39% |
| Mar 31, 2022 | -29.75% |
| Dec 31, 2021 | -24.75% |
| Sep 30, 2021 | -21.51% |
| Jun 30, 2021 | -18.41% |